###begin article-title 0
Cthrc1 Is a Positive Regulator of Osteoblastic Bone Formation
###end article-title 0
###begin p 1
Conceived and designed the experiments: BdC HA. Performed the experiments: HK KMK BGD HA. Analyzed the data: HK BGD RRB TN HA. Contributed reagents/materials/analysis tools: ZZ JMD RRB BdC. Wrote the paper: HK BdC HA.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Bone mass is maintained by continuous remodeling through repeated cycles of bone resorption by osteoclasts and bone formation by osteoblasts. This remodeling process is regulated by many systemic and local factors.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 270 276 270 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 307 314 307 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 372 378 372 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 427 433 427 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 450 456 450 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 558 564 558 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 661 667 661 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 788 794 788 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 823 829 823 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 920 928 920 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 999 1005 999 1005 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 1019 1025 1019 1025 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 1183 1186 1183 1186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALP</italic>
###xml 1188 1194 1188 1194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col1a1</italic>
###xml 1200 1211 1200 1211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Osteocalcin</italic>
###xml 1254 1260 1254 1260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 1288 1294 1288 1294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 1421 1429 1421 1429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1434 1441 1434 1441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 384 388 <span type="species:ncbi:10090">mice</span>
###xml 393 408 <span type="species:ncbi:10090">transgenic mice</span>
###xml 457 472 <span type="species:ncbi:10090">transgenic mice</span>
###xml 570 574 <span type="species:ncbi:10090">mice</span>
###xml 668 683 <span type="species:ncbi:10090">transgenic mice</span>
###xml 800 804 <span type="species:ncbi:10090">mice</span>
###xml 830 845 <span type="species:ncbi:10090">transgenic mice</span>
###xml 914 918 <span type="species:ncbi:10090">mice</span>
###xml 1011 1015 <span type="species:ncbi:10090">mice</span>
###xml 1026 1041 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1266 1270 <span type="species:ncbi:10090">mice</span>
###xml 1295 1310 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1488 1503 <span type="species:ncbi:10090">transgenic mice</span>
We identified collagen triple helix repeat containing-1 (Cthrc1) as a downstream target of bone morphogenetic protein-2 (BMP2) in osteochondroprogenitor-like cells by PCR-based suppression subtractive hybridization followed by differential hybridization, and found that Cthrc1 was expressed in bone tissues in vivo. To investigate the role of Cthrc1 in bone, we generated Cthrc1-null mice and transgenic mice which overexpress Cthrc1 in osteoblasts (Cthrc1 transgenic mice). Microcomputed tomography (micro-CT) and bone histomorphometry analyses showed that Cthrc1-null mice displayed low bone mass as a result of decreased osteoblastic bone formation, whereas Cthrc1 transgenic mice displayed high bone mass by increase in osteoblastic bone formation. Osteoblast number was decreased in Cthrc1-null mice, and increased in Cthrc1 transgenic mice, respectively, while osteoclast number had no change in both mutant mice. In vitro, colony-forming unit (CFU) assays in bone marrow cells harvested from Cthrc1-null mice or Cthrc1 transgenic mice revealed that Cthrc1 stimulated differentiation and mineralization of osteoprogenitor cells. Expression levels of osteoblast specific genes, ALP, Col1a1, and Osteocalcin, in primary osteoblasts were decreased in Cthrc1-null mice and increased in Cthrc1 transgenic mice, respectively. Furthermore, BrdU incorporation assays showed that Cthrc1 accelerated osteoblast proliferation in vitro and in vivo. In addition, overexpression of Cthrc1 in the transgenic mice attenuated ovariectomy-induced bone loss.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
Our results indicate that Cthrc1 increases bone mass as a positive regulator of osteoblastic bone formation and offers an anabolic approach for the treatment of osteoporosis.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 473 476 473 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-Olsen1">[1]</xref>
###xml 477 480 477 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-Harada1">[3]</xref>
Bone modeling is initiated by osteoblastic differentiation of mesenchymal cells into preosteoblasts. Preosteoblasts then differentiate into functional osteoblasts producing bone matrix proteins, including type I collagen, osteopontin, and osteocalcin to form bone tissues. Bone is constantly remodeled through bone formation by functional osteoblasts and bone resorption by osteoclasts which arise from monocytic cells, and bone mass is maintained by their precise balance [1]-[3]. Recently, significant advances have been made in our understandings of the factors that regulate the balance between osteoblastic bone formation and osteoclastic bone resorption, but the mechanisms have not been fully elucidated.
###end p 9
###begin p 10
###xml 241 244 241 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-Hughes1">[4]</xref>
###xml 245 248 245 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-Kronenberg1">[6]</xref>
###xml 367 370 367 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-Abe2">[7]</xref>
###xml 479 482 479 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-Devlin1">[8]</xref>
###xml 483 487 483 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-Yoshida1">[12]</xref>
###xml 509 515 509 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmpr1a</italic>
###xml 759 763 759 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-Mishina1">[11]</xref>
###xml 822 828 822 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">noggin</italic>
###xml 949 952 949 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-Devlin1">[8]</xref>
###xml 954 957 954 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-Wu1">[9]</xref>
###xml 996 999 996 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tob</italic>
###xml 1238 1242 1238 1242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-Yoshida1">[12]</xref>
###xml 446 450 <span type="species:ncbi:10090">mice</span>
###xml 526 530 <span type="species:ncbi:10090">mice</span>
###xml 765 780 <span type="species:ncbi:10090">Transgenic mice</span>
###xml 959 963 <span type="species:ncbi:10090">Mice</span>
Bone morphogenetic proteins (BMPs) are potent osteogenic agents that induce differentiation of mesenchymal cells toward an osteoblastic lineage and stimulate the differentiation and functions of osteoblasts during a process of bone modeling [4]-[6]. Postnatally, BMP signaling regulates osteoblastic bone formation and osteoclastic bone resorption in bone remodeling [7]. Recent studies show that osteoblast-specific inhibition of BMP signals in mice affects postnatal bone mass [8]-[12]. Osteoblast-specific Bmpr1a deficient mice show reduced bone volume and bone formation rates with normal osteoblast number due to impaired osteoblast function at 3 months old and increased bone volume probably due to reduced osteoclastic bone resorption at 10 months old [11]. Transgenic mice that osteoblast-specifically overexpress noggin, the BMP inhibitor, display reduced bone mineral densities and bone formation rates due to impaired osteoblast function [8], [9]. Mice carrying a targeted deletion of Tob, which is a member of a new antiproliferative protein family and represses BMP-induced Smad-dependent transcription in osteoblasts, have increased bone mass due to increased osteoblast numbers and acceleration of the bone formation rates [12]. Thus, BMPs are key molecules that control bone modeling and bone remodeling.
###end p 10
###begin p 11
###xml 639 643 635 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-Pyagay1">[13]</xref>
###xml 645 651 641 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 847 851 843 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-Pyagay1">[13]</xref>
###xml 1028 1034 1024 1030 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 1081 1085 1077 1081 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-LeClair1">[14]</xref>
###xml 1123 1129 1119 1125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 1154 1160 1150 1156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 1269 1273 1265 1269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-Durmus1">[15]</xref>
###xml 997 1012 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1264 1268 <span type="species:ncbi:10090">mice</span>
To identify the molecules that regulate bone modeling and/or bone remodeling as a downstream target of BMP signaling, we compared the mRNAs expressed in BMP2-untreated and BMP2-treated ATDC5 osteochondroprogenitor-like cells by PCR-based suppression subtractive hybridization followed by differential hybridization, and identified a cDNA upregulated by BMP2, that encoded Collagen triple helix repeat containing protein 1 (Cthrc1). Cthrc1 is a 30-kD glycosylated secreted protein containing a short collagen-like motif with 12 Gly-X-Y repeats similar to the collagen domains present in the C1q/tumor necrosis factor alpha related proteins [13]. Cthrc1 is transiently expressed in the arterial wall in response to injury, suggesting that Cthrc1 is involved in vascular remodeling by limiting collagen matrix deposition and promoting cell migration [13]. A recent study shows that neointimal lesion formation and adventitial collagen deposition in response to carotid artery ligation are reduced in transgenic mice overexpressing Cthrc1 under the control of cytomegalovirus promoter [14]. According to expression analysis of Cthrc1, abundant expression of Cthrc1 is observed in developing skeleton during embryogenesis and in the bone matrix and periosteum in adult mice [15].
###end p 11
###begin p 12
###xml 28 34 28 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 82 88 82 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 110 116 110 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col1a1</italic>
###xml 147 153 147 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 337 345 337 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 40 44 <span type="species:ncbi:10090">mice</span>
###xml 49 64 <span type="species:ncbi:10090">transgenic mice</span>
###xml 159 163 <span type="species:ncbi:10090">mice</span>
###xml 249 264 <span type="species:ncbi:10090">transgenic mice</span>
In this study, we generated Cthrc1-null mice and transgenic mice that overexpress Cthrc1 under the control of Col1a1 osteoblast-specific promoter. Cthrc1-null mice developed a low-bone-mass-phenotype as a result of reduced bone formation, while the transgenic mice exhibited a high-bone-mass-phenotype caused by enhanced bone formation. In vitro analyses showed that Cthrc1 stimulated osteoblast proliferation and differentiation. Thus, our results indicate that Cthrc1 is a positive regulator of osteoblastic bone formation.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
Cthrc1 is expressed in bone
###end title 14
###begin p 15
###xml 225 226 225 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 329 339 329 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003174.s001">Figure S1A</xref>
###xml 342 350 342 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 352 358 352 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 504 514 504 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003174.s001">Figure S1B</xref>
###xml 552 558 552 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 621 627 621 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 701 711 701 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003174.s001">Figure S1C</xref>
###xml 775 781 775 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 871 881 871 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003174.s001">Figure S1D</xref>
###xml 922 928 922 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 967 977 967 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003174.s001">Figure S1E</xref>
###xml 576 581 <span type="species:ncbi:10090">mouse</span>
###xml 677 682 <span type="species:ncbi:10090">mouse</span>
###xml 760 765 <span type="species:ncbi:10090">mouse</span>
###xml 946 951 <span type="species:ncbi:10090">mouse</span>
To identify potential osteoblast-specific proteins as downstreams of BMPs, we performed two-step screening consisting of PCR-based suppression subtractive hybridization followed by differential hybridization using the poly(A)+ RNA extracted from BMP2-untreated and BMP2-treated ATDC5 cells, and identified a cDNA encoding Cthrc1(Figure S1A). In vitro, Cthrc1 was expressed in MC3T3-E1 osteoblastic cells and differentiated ATDC5 cells, but not in C3H10T1/2 fibroblastic cells and C2C12 myoblastic cells (Figure S1B). We next assessed the expression of Cthrc1 in various adult mouse tissues by northern blot analysis, and Cthrc1 was expressed in bone but not in the other adult mouse tissues examined (Figure S1C). During the skeletogenesis in the limb buds of mouse embryos, Cthrc1 was expressed in the mesenchymal condensation in E13.5 and in the bone tissues in E16.5 (Figure S1D). In addition, the expression levels of Cthrc1 increased during mouse embryogenesis (Figure S1E). These results suggest that Cthrc1 plays an important role in bone modeling or remodeling.
###end p 15
###begin title 16
###xml 46 52 46 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 58 62 <span type="species:ncbi:10090">mice</span>
Low bone mass and decreased bone formation in Cthrc1-null mice
###end title 16
###begin p 17
###xml 76 82 76 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 174 191 174 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRES-lacZ-pA-loxP</italic>
###xml 332 348 332 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003174-g001">Figure 1 A and B</xref>
###xml 363 372 363 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003174-g001">Figure 1C</xref>
###xml 405 411 405 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 486 492 486 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 661 667 661 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 710 716 710 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 855 862 855 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 878 887 878 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003174-g001">Figure 1D</xref>
###xml 892 902 892 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003174.s002">Figure S2A</xref>
###xml 968 974 968 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 994 1004 994 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003174.s002">Figure S2B</xref>
###xml 1007 1014 1007 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In situ</italic>
###xml 1095 1100 1095 1100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Runx2</italic>
###xml 1105 1111 1105 1111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col1a1</italic>
###xml 1143 1149 1143 1149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col2a1</italic>
###xml 1154 1161 1154 1161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col10a1</italic>
###xml 1176 1182 1176 1182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 1229 1239 1229 1239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003174.s003">Figure S3A</xref>
###xml 1453 1459 1453 1459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 1741 1747 1741 1747 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 1841 1847 1841 1847 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 1907 1923 1907 1923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003174-g002">Figure 2 A and B</xref>
###xml 2064 2070 2064 2070 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 2218 2224 2218 2224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 2236 2247 2236 2247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003174-g002">Figure 2C&#8211;E</xref>
###xml 2252 2262 2252 2262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003174.s004">Figure S4A</xref>
###xml 2314 2320 2314 2320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 2623 2629 2623 2629 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 2655 2664 2655 2664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003174-g002">Figure 2F</xref>
###xml 2669 2679 2669 2679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003174.s004">Figure S4A</xref>
###xml 2718 2725 2718 2725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 2785 2791 2785 2791 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 2915 2921 2915 2921 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 2933 2942 2933 2942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003174-g002">Figure 2G</xref>
###xml 3092 3098 3092 3098 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 3110 3119 3110 3119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003174-g002">Figure 2H</xref>
###xml 3183 3189 3183 3189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 91 96 <span type="species:ncbi:10090">mouse</span>
###xml 500 504 <span type="species:ncbi:10090">mice</span>
###xml 988 992 <span type="species:ncbi:10090">mice</span>
###xml 1465 1469 <span type="species:ncbi:10090">mice</span>
###xml 1767 1771 <span type="species:ncbi:10090">mice</span>
###xml 1853 1857 <span type="species:ncbi:10090">mice</span>
###xml 1901 1905 <span type="species:ncbi:10090">mice</span>
###xml 2076 2080 <span type="species:ncbi:10090">mice</span>
###xml 2230 2234 <span type="species:ncbi:10090">mice</span>
###xml 2326 2330 <span type="species:ncbi:10090">mice</span>
###xml 2460 2464 <span type="species:ncbi:10090">mice</span>
###xml 2649 2653 <span type="species:ncbi:10090">mice</span>
###xml 2927 2931 <span type="species:ncbi:10090">mice</span>
###xml 3104 3108 <span type="species:ncbi:10090">mice</span>
###xml 3195 3199 <span type="species:ncbi:10090">mice</span>
To investigate the physiological role of Cthrc1 in bone, we inactivated the Cthrc1 gene in mouse embryonic stem cells by homologous recombination. In the target strategy, an IRES-lacZ-pA-loxP-flanked neomycin resistance expression cassette was introduced into exon 2 which codes a short Gly-X-Y collagen triple helix repeat domain (Figure 1 A and B). As shown in Figure 1C, Cthrc1 RNA was absent in E16.5 Cthrc1-null embryo, indicating that the mutation was a null mutation. Homozygous Cthrc1 mutant mice were born at the expected Mendelian ratio and grew normally in comparison with their wild-type littermates (data not shown). X-gal staining of heterozygous Cthrc1 mutant embryos revealed the expression of Cthrc1 in bone-forming tissues in E12.5 embryos and in bones and periarticular cartilages in E16.5 embryos, which corresponded to the results of in situ hybridization (Figure 1D and Figure S2A). Skeletal preparations showed no obvious skeletal phenotypes in Cthrc1-null newborn mice (Figure S2B). In situ hybridization analyses showed comparable expression of osteoblast marker genes, Runx2 and Col1a1, and chondrocyte marker genes, Col2a1 and Col10a1 between E16.5 Cthrc1-null embryos and their wild-type littermates (Figure S3A), suggesting that Cthrc1 has no apparent effect on skeletal development. However, histological analyses of decalcified adult bone tissues revealed that the number and thickness of trabecular bones were reduced in Cthrc1-null mice, compared with their wild-type littermates (data not shown). This result suggested that Cthrc1 may regulate bone remodeling postnatally. To test this hypothesis, we performed bone histomorphometric analyses and microcomputed tomography (micro-CT) analyses of 2-month-old Cthrc1-null and wild-type mice. Micro-CT analyses of tibiae showed that the trabecular bone mass in Cthrc1-null mice was approximately 70% of that in wild-type mice (Figure 2 A and B). Bone histomorphometric and micro-CT analyses showed a significant decrease in trabecular number (Tb.N) and osteoblast number (Ob.N/BS) in Cthrc1-null mice, while trabecular thickness (Tb.Th) and tartrate-resistant acid phosphatase (TRAP)-positive osteoclast number (Oc.N/BS) had no change in Cthrc1-null mice (Figure 2C-E and Figure S4A). In addition, the osteoblast surface (Ob.S/BS) in Cthrc1-null mice, which represents the proportion of the bone surface covered with osteoblasts, was approximately 40% less than that in wild-type mice, and the osteoclast surface (Oc.S/BS), which represents the proportion of the bone surface covered with osteoclasts, showed no significant difference between Cthrc1-null and wild-type mice (Figure 2F and Figure S4A). To analyze osteoblast proliferation in vivo, we performed BrdU incorporation assays in the calvaria of Cthrc1-null and wild-type littermates, and found that the percentage of proliferating cells was decreased by approximately 30% in Cthrc1-null mice (Figure 2G). Moreover, double-labeling analyses with calcein, a marker of newly formed bone, showed that the bone formation rate was significantly decreased in Cthrc1-null mice (Figure 2H). Thus, these results indicate that the decreased bone mass in Cthrc1-null mice is due to the suppression of osteoblastic bone formation, not due to an acceleration of osteoclastic bone resorption.
###end p 17
###begin title 18
###xml 14 20 14 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 26 30 <span type="species:ncbi:10090">mice</span>
Generation of Cthrc1-null mice.
###end title 18
###begin p 19
###xml 29 35 29 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 607 613 607 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 648 654 648 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 726 732 726 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 765 771 765 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 788 794 788 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 755 759 <span type="species:ncbi:10090">mice</span>
###xml 777 781 <span type="species:ncbi:10090">mice</span>
###xml 808 812 <span type="species:ncbi:10090">mice</span>
(A) Structure of the genomic Cthrc1 locus, targeting vector, and targeting allele. Exons are depicted as closed boxes, and intronic sequences are shown as solid lines. IRES-LacZ-pA-loxP-flanked PGK-neo-bpA cassettes are depicted as open boxes. S, SacI; B, BamHI. (B) Southern blot analysis of fetal genomic DNA. Genomic DNA isolated from the skin was digested with SacI and then hybridized with the 5' or 3' probe. The wild-type and the mutant allele were detected with the 5' probe as 13.1-kb and 6.5-kb fragments and with the 3' probe as 13.1-kb and 9.1-kb fragments, respectively. (C) RT-PCR analysis of Cthrc1 transcript in E16.5 wild-type and Cthrc1-null littermates. (D) Whole-mount X-gal staining of E16.5 heterozygous Cthrc1 embryo. WT: wild-type mice; KO: Cthrc1-null mice; +/-: Cthrc1 heterozygous mice.
###end p 19
###begin title 20
###xml 19 25 19 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 31 35 <span type="species:ncbi:10090">mice</span>
Bone phenotypes of Cthrc1-null mice.
###end title 20
###begin p 21
###xml 49 55 49 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 259 265 259 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 464 470 464 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 624 630 624 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 707 713 707 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 759 760 757 758 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 760 761 758 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
###xml 285 289 <span type="species:ncbi:10090">mice</span>
###xml 490 494 <span type="species:ncbi:10090">mice</span>
###xml 650 654 <span type="species:ncbi:10090">mice</span>
###xml 697 701 <span type="species:ncbi:10090">mice</span>
###xml 719 723 <span type="species:ncbi:10090">mice</span>
(A-D) Micro-CT analyses of tibiae in 2-month-old Cthrc1-null and wild-type mice (n = 6). Bone volume/total volume (BV/TV), trabecular number (Tb.N), trabecular thickness (Tb.Th) are shown. (E and F) Bone histomorphometric analyses of vertebrae in 2-month-old Cthrc1-null and wild-type mice (n = 6). Osteoblast number/bone surface (Ob.N/BS) and osteoblast surface/bone surface (Ob.S/BS) are shown. (G) Analyses of osteoblast proliferation in calvaria of 1-week-old Cthrc1-null and wild-type mice by BrdU incorporation assays. Arrows indicate BrdU positive osteoblasts. (H) Calcein double-labeling of vertebrae in 2-month-old Cthrc1-null and wild-type mice. BFR : Bone formation rate. WT: wild-type mice; KO: Cthrc1-null mice. Data are shown as the mean+/-SEM (*p<0.05).
###end p 21
###begin title 22
###xml 78 84 78 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 47 62 <span type="species:ncbi:10090">transgenic mice</span>
High bone mass and increased bone formation in transgenic mice overexpressing Cthrc1 in osteoblasts
###end title 22
###begin p 23
###xml 138 144 138 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 185 191 185 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col1a1</italic>
###xml 229 238 229 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003174-g003">Figure 3A</xref>
###xml 404 413 404 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003174-g003">Figure 3B</xref>
###xml 427 433 427 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 675 685 675 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003174.s002">Figure S2C</xref>
###xml 701 708 701 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 843 848 843 848 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Runx2</italic>
###xml 853 859 853 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col1a1</italic>
###xml 886 892 886 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col2a1</italic>
###xml 897 904 897 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col10a1</italic>
###xml 930 940 930 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003174.s003">Figure S3B</xref>
###xml 988 994 988 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 1032 1038 1032 1038 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 1135 1141 1135 1141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 1217 1232 1217 1232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003174-g003">Figure 3C and D</xref>
###xml 1537 1548 1537 1548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003174-g003">Figure 3E&#8211;G</xref>
###xml 1553 1563 1553 1563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003174.s004">Figure S4C</xref>
###xml 1787 1796 1787 1796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003174-g003">Figure 3H</xref>
###xml 1801 1811 1801 1811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003174.s004">Figure S4C</xref>
###xml 1951 1960 1951 1960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003174-g003">Figure 3I</xref>
###xml 2086 2095 2086 2095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003174-g003">Figure 3J</xref>
###xml 2158 2164 2158 2164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 78 93 <span type="species:ncbi:10090">transgenic mice</span>
###xml 434 449 <span type="species:ncbi:10090">transgenic mice</span>
###xml 658 673 <span type="species:ncbi:10090">transgenic mice</span>
###xml 915 920 <span type="species:ncbi:10090">mouse</span>
###xml 1000 1004 <span type="species:ncbi:10090">mice</span>
###xml 1039 1054 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1142 1157 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1211 1215 <span type="species:ncbi:10090">mice</span>
###xml 1381 1396 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1501 1516 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1531 1535 <span type="species:ncbi:10090">mice</span>
###xml 1602 1617 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1671 1675 <span type="species:ncbi:10090">mice</span>
###xml 1751 1766 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1781 1785 <span type="species:ncbi:10090">mice</span>
###xml 1934 1949 <span type="species:ncbi:10090">transgenic mice</span>
###xml 2069 2084 <span type="species:ncbi:10090">transgenic mice</span>
###xml 2165 2180 <span type="species:ncbi:10090">transgenic mice</span>
To determine if Cthrc1 is sufficient to increase bone mass, we next generated transgenic mice that specifically overexpressed 3xHA tagged Cthrc1 in osteoblasts under the control of the Col1a1 2.3 kb osteoblast-specific promoter (Figure 3A). Immunohistochemistry with antibody against the HA-epitope tag showed specific expression of 3xHA tagged protein in bone collars, periosteum, and trabecular bones (Figure 3B). Hemizygous Cthrc1 transgenic mice were born at the expected Mendelian ratio and grew normally in comparison with their wild-type littermates (data not shown). Skeletal preparations showed no apparent skeletal phenotypes in newborn hemizygous transgenic mice (Figure S2C). In addition, in situ hybridization analyses revealed that overexpression of Cthrc1 in osteoblasts did not affect the expression of the osteoblast markers, Runx2 and Col1a1, and chondrocyte markers, Col2a1 and Col10a1, in E16.5 mouse embryos (Figure S3B). As we found an osteopenic phenotype in adult Cthrc1-null mice, we analyzed bone in adult Cthrc1 transgenic mice. Micro-CT analyses of tibiae showed that the trabecular bone mass in hemizygous Cthrc1 transgenic mice was approximately 25% greater than that in wild-type mice (Figure 3C and D). Likewise, bone histomorphometric and micro-CT analyses showed significant increase in trabecular number (Tb.N) and osteoblast number (Ob.N/BS) in transgenic mice, while trabecular thickness (Tb.Th) and TRAP-positive osteoclast number (Oc.N/BS) had no change between transgenic mice and wild-type mice (Figure 3E-G and Figure S4C). The osteoblast surface (Ob.S/BS) in transgenic mice was approximately 40% greater than that in wild-type mice, while there was no difference in the osteoclast surface (Oc.S/BS) between transgenic mice and wild-type mice (Figure 3H and Figure S4C). BrdU incorporation assays showed that the percentage of proliferating osteoblasts was increased by approximately 35% in transgenic mice (Figure 3I). Furthermore, double-labeling analyses with calcein showed a marked increase in the bone formation rate in transgenic mice (Figure 3J). Thus, these data indicate that the increase in bone mass in Cthrc1 transgenic mice is due to the stimulation of osteoblastic bone formation.
###end p 23
###begin title 24
###xml 14 20 14 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 21 36 <span type="species:ncbi:10090">transgenic mice</span>
Generation of Cthrc1 transgenic mice and analyses of bone phenotypes.
###end title 24
###begin p 25
###xml 36 49 36 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col1a1-Cthrc1</italic>
###xml 206 212 206 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 279 285 279 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 498 504 498 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 709 715 709 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 875 881 875 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 963 969 963 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 1021 1022 1019 1020 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 1022 1023 1020 1021 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 69 73 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 213 228 <span type="species:ncbi:10090">transgenic mice</span>
###xml 311 315 <span type="species:ncbi:10090">mice</span>
###xml 530 534 <span type="species:ncbi:10090">mice</span>
###xml 741 745 <span type="species:ncbi:10090">mice</span>
###xml 907 911 <span type="species:ncbi:10090">mice</span>
###xml 953 957 <span type="species:ncbi:10090">mice</span>
###xml 970 985 <span type="species:ncbi:10090">transgenic mice</span>
(A) Schematic representation of the Col1a1-Cthrc1 transgene. Poly A: SV40 polyadenylation signal. Arrows indicate the primers for genotyping. (B) Expression of 3xHA-tagged Cthrc1 protein in humeri of E16.5 Cthrc1 transgenic mice. (C-F) Micro-CT analyses of tibiae in 2-month-old Cthrc1 transgenic and wild-type mice (n = 6). Bone volume/total volume (BV/TV), trabecular number (Tb.N) and trabecular thickness (Tb.Th) are shown. (G and H) Bone histomorphometric analyses of vertebrae in 2-month-old Cthrc1 transgenic and wild-type mice (n = 6). Osteoblast number/bone surface (Ob.N/BS) and osteoblast surface/bone surface (Ob.S/BS) are shown. (I) Analyses of osteoblast proliferation in calvaria of 1-week-old Cthrc1 transgenic and wild-type mice by BrdU incorporation assays. Arrows indicate BrdU positive osteoblasts. (J) Calcein double-labeling of vertebrae in 2-month-old Cthrc1 transgenic and wild-type mice. BFR: Bone formation rate. WT: wild-type mice; Tg: Cthrc1 transgenic mice. Data are shown as the mean+/-SEM (*p<0.05).
###end p 25
###begin title 26
Cthrc1 stimulates osteoblast proliferation and differentiation
###end title 26
###begin p 27
###xml 158 165 158 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 274 280 274 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 280 283 280 283 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 301 307 301 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 314 320 314 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 320 323 320 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 433 441 433 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 465 471 465 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 471 474 471 474 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 513 519 513 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 519 522 519 522 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 536 545 536 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003174-g004">Figure 4A</xref>
###xml 634 637 634 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALP</italic>
###xml 639 645 639 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col1a1</italic>
###xml 651 662 651 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Osteocalcin</italic>
###xml 685 691 685 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 691 694 691 694 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 792 797 788 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RANKL</italic>
###xml 859 868 855 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003174-g004">Figure 4B</xref>
###xml 873 883 869 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003174.s004">Figure S4B</xref>
###xml 907 915 903 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1053 1059 1049 1055 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 1059 1062 1055 1058 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1209 1215 1205 1211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 1215 1218 1211 1214 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1288 1303 1284 1299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003174-g004">Figure 4C and D</xref>
###xml 1401 1407 1397 1403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 1441 1449 1437 1445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1463 1472 1459 1468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003174-g004">Figure 4A</xref>
###xml 1582 1585 1578 1581 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALP</italic>
###xml 1587 1593 1583 1589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col1a1</italic>
###xml 1599 1610 1595 1606 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Osteocalcin</italic>
###xml 1681 1686 1677 1682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RANKL</italic>
###xml 1703 1712 1699 1708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003174-g004">Figure 4B</xref>
###xml 1717 1727 1713 1723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003174.s004">Figure S4D</xref>
###xml 1849 1855 1845 1851 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 1873 1888 1869 1884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003174-g004">Figure 4C and D</xref>
###xml 62 67 <span type="species:ncbi:10090">mouse</span>
###xml 345 349 <span type="species:ncbi:10090">mice</span>
###xml 1408 1423 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1856 1871 <span type="species:ncbi:10090">transgenic mice</span>
Both the loss-of-function and gain-of-function analyses using mouse genetics approaches indicate that Cthrc1 positively regulates osteoblastic bone formation in vivo. To clarify the functions of Cthrc1 in osteoblasts, we isolated osteoblasts from the calvaria of wild-type (Cthrc1+/+ osteoblasts) and Cthrc1-null (Cthrc1-/- osteoblasts) newborn mice and analyzed the effects of Cthrc1 on osteoblast proliferation and differentiation in vitro. BrdU incorporation in Cthrc1-/- osteoblasts was 40% less than that in Cthrc1+/+ osteoblasts (Figure 4A). Real-time PCR analyses confirmed that the mRNA levels of the osteoblast marker genes, ALP, Col1a1, and Osteocalcin were all decreased in Cthrc1-/- osteoblasts, whereas the expression level of receptor activator of nuclear factor kappaB ligand (RANKL), a major determinant of osteoclastogenesis, did not differ (Figure 4B and Figure S4B). We further performed in vitro analyses of osteoprogenitor frequency and differentiation capacity by colony-forming unit (CFU) assays. CFU-ALP assays demonstrated that Cthrc1-/- bone marrow cells had dramatically reduced osteoprogenitors, and mineralized area of CFU-osteoblast (CFU-O) was also reduced by more than half in Cthrc1-/- bone marrow cells, consistent with decreased functional progenitors (Figure 4C and D). Likewise, we examined osteoblast proliferation and differentiation in osteoblasts derived from Cthrc1 transgenic mice (Tg-osteoblasts) in vitro. As shown in Figure 4A, BrdU incorporation in Tg-osteoblasts was 25% greater than that in wild-type osteoblasts. The mRNA levels of ALP, Col1a1, and Osteocalcin were all increased in Tg-osteoblasts, whereas the expression level of RANKL did not differ (Figure 4B and Figure S4D). CFU assays showed that the frequency of osteoprogenitors and mineralized area of CFU-O were significantly increased in Cthrc1 transgenic mice (Figure 4C and D). Thus, these results indicate that Cthrc1 accelerates bone formation by stimulating osteoblast proliferation and differentiation, resulting in increased postnatal bone volume.
###end p 27
###begin title 28
Effects of Cthrc1 on osteogenesis.
###end title 28
###begin p 29
###xml 61 67 61 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 101 107 101 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 272 278 272 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 307 313 307 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 420 426 420 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 448 454 448 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 556 562 556 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 584 590 584 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 640 646 640 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 662 668 662 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 720 721 718 719 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 721 722 719 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 73 77 <span type="species:ncbi:10090">mice</span>
###xml 108 123 <span type="species:ncbi:10090">transgenic mice</span>
###xml 284 288 <span type="species:ncbi:10090">mice</span>
###xml 314 329 <span type="species:ncbi:10090">transgenic mice</span>
###xml 432 436 <span type="species:ncbi:10090">mice</span>
###xml 455 470 <span type="species:ncbi:10090">transgenic mice</span>
###xml 568 572 <span type="species:ncbi:10090">mice</span>
###xml 591 606 <span type="species:ncbi:10090">transgenic mice</span>
###xml 630 634 <span type="species:ncbi:10090">mice</span>
###xml 652 656 <span type="species:ncbi:10090">mice</span>
###xml 669 684 <span type="species:ncbi:10090">transgenic mice</span>
(A) Cell proliferation in primary osteoblasts harvested from Cthrc1-null mice (upper panel) and from Cthrc1 transgenic mice (lower panel) as shown by BrdU incorporation assays. (B) Expression of early and late osteoblast marker genes in primary osteoblasts harvested from Cthrc1-null mice (upper panel) and Cthrc1 transgenic mice (lower panel). (C) The total numbers of CFU-ALP in bone marrow cell cultures derived from Cthrc1-null mice (left) and Cthrc1 transgenic mice (right). (D) The mineralized area of CFU-O in bone marrow cell cultures derived from Cthrc1-null mice (left) and Cthrc1 transgenic mice (right). WT: wild-type mice; KO: Cthrc1-null mice; Tg: Cthrc1 transgenic mice. Data are shown as the mean+/-SEM (*p<0.05).
###end p 29
###begin title 30
Cthrc1 attenuates ovariectomy (OVX)-induced bone loss
###end title 30
###begin p 31
###xml 194 198 194 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-Kalu1">[16]</xref>
###xml 215 221 215 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 464 479 464 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003174-g005">Figure 5A and B</xref>
###xml 773 782 773 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003174-g005">Figure 5C</xref>
###xml 925 934 925 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003174-g005">Figure 5D</xref>
###xml 1165 1174 1165 1174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003174-g005">Figure 5E</xref>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
###xml 247 251 <span type="species:ncbi:10090">mice</span>
###xml 429 433 <span type="species:ncbi:10090">mice</span>
###xml 447 462 <span type="species:ncbi:10090">transgenic mice</span>
###xml 514 529 <span type="species:ncbi:10090">transgenic mice</span>
###xml 585 589 <span type="species:ncbi:10090">mice</span>
###xml 665 680 <span type="species:ncbi:10090">transgenic mice</span>
###xml 743 747 <span type="species:ncbi:10090">mice</span>
###xml 756 771 <span type="species:ncbi:10090">transgenic mice</span>
###xml 842 846 <span type="species:ncbi:10090">mice</span>
###xml 908 923 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1147 1162 <span type="species:ncbi:10090">transgenic mice</span>
In view of an anabolic effect of Cthrc1 on bone formation, we tested whether Cthrc1 may impact bone mass in the OVX mice, an established preclinical disease model of postmenopausal osteoporosis [16]. Eight-week-old Cthrc1 transgenic and wild-type mice were ovariectomized or sham-operated, and four weeks after operation, metaphyseal regions of tibiae were analyzed by micro-CT. OVX induced 47% trabecular bone loss in wild-type mice, and 38%, in transgenic mice (Figure 5A and B), and trabecular bone mass in OVX transgenic mice was only 17% less than that in sham-operated wild-type mice. Trabecular number, which was reduced by ovariectomy in both wild-type and transgenic mice, did not significantly differ between sham-operated wild-type mice and OVX transgenic mice (Figure 5C). Trabecular thickness, which was reduced in OVX wild-type mice, had no significant difference between sham-operated and OVX transgenic mice (Figure 5D). These results indicated that stimulatory effect of Cthrc1 on bone formation partly prevents reduction in bone volume by ovariectomy. Indeed, increase in bone formation rates was maintained after ovariectomy in transgenic mice. (Figure 5E). Thus, Cthrc1 attenuates estrogen deficiency-induced bone loss by enhanced osteoclastic bone resorption through stimulating osteoblastic bone formation.
###end p 31
###begin title 32
###xml 39 45 39 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 46 61 <span type="species:ncbi:10090">transgenic mice</span>
OVX-induced bone loss is attenuated in Cthrc1 transgenic mice.
###end title 32
###begin p 33
###xml 40 46 40 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 365 371 365 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 423 424 421 422 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 424 425 422 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
###xml 355 359 <span type="species:ncbi:10090">mice</span>
###xml 372 387 <span type="species:ncbi:10090">transgenic mice</span>
(A) micro-CT of tibiae from 3-month-old Cthrc1 transgenic and wild-type mice which were sham-operated or ovariectomized at 2 months of age (n = 5). (B-E) Bone volume/total volume (BV/TV) (B), trabecular number (Tb.N) (C), trabecular thickness (Tb.Th) (D) and bone formation rate (BFR) (E) were assessed by micro-CT or bone histomorphometry. WT: wild-type mice; Tg: Cthrc1 transgenic mice. Data are shown as the mean+/-SEM (*p<0.05).
###end p 33
###begin title 34
Discussion
###end title 34
###begin p 35
###xml 155 158 155 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-Karsenty1">[2]</xref>
###xml 356 359 350 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-Harada1">[3]</xref>
###xml 361 364 355 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-Abe2">[7]</xref>
###xml 445 451 439 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 572 578 566 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 687 695 681 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 786 789 780 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALP</italic>
###xml 791 797 785 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col1a1</italic>
###xml 803 814 797 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Osteocalcin</italic>
###xml 1015 1023 1009 1017 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1028 1035 1022 1029 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1134 1141 1128 1135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1146 1151 1140 1145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RANKL</italic>
###xml 457 461 <span type="species:ncbi:10090">mice</span>
###xml 579 594 <span type="species:ncbi:10090">transgenic mice</span>
Bone mass is regulated by continuous remodeling which is based on the balanced action between osteoblastic bone formation and osteoclastic bone resorption [2]. This process is precisely coordinated to maintain the bone mass homeostasis mediated by multiple signaling pathways such as parathyroid hormone, transforming growth factor-beta (TGF-beta) and BMP [3], [7]. In this study, we show that Cthrc1 is involved in postnatal bone formation. In Cthrc1-null mice, bone volume, trabecular number, osteoblast number, and bone formation rates were significantly decreased. In Cthrc1 transgenic mice, bone volume, trabecular number, osteoblast number and bone formation rates were increased. In vitro, CFU assays in bone marrow cells and analyses of expression of osteoblast specific genes, ALP, Col1a1, and Osteocalcin, in osteoblasts revealed that Cthrc1 stimulates differentiation of osteoprogenitor cells and osteoblasts. Furthermore, BrdU incorporation assays showed that Cthrc1 stimulates osteoblast proliferation in vitro and in vivo. In contrast, Cthrc1 did not affect either TRAP-positive osteoclast number and osteoclast surface in vivo, or RANKL expression levels in primary osteoblasts. These findings indicate that Cthrc1 acts as a stimulator of osteoblastic bone formation, but has no effect on osteoclastic bone resorption.
###end p 35
###begin p 36
###xml 113 116 113 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-Kronenberg1">[6]</xref>
###xml 118 122 118 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-Yoshida1">[12]</xref>
###xml 124 128 124 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-Wozney1">[17]</xref>
###xml 269 272 269 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-Devlin1">[8]</xref>
###xml 273 277 273 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-Yoshida1">[12]</xref>
###xml 424 430 421 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 430 434 427 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-Pyagay1">[13]</xref>
###xml 436 440 433 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-Tang1">[18]</xref>
###xml 738 741 735 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALP</italic>
###xml 743 765 740 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col1a1 and Osteocalcin</italic>
###xml 208 212 <span type="species:ncbi:10090">mice</span>
BMPs have potent osteogenic effects and control osteoblast proliferation and differentiation during osteogenesis [6], [12], [17]. Several studies of cell-specific inactivation or activation of BMP signals in mice have shown that BMPs regulate postnatal bone remodeling [8]-[12]. As shown in previous studies, Cthrc1 is regulated by TGF-beta and BMP4, and a putative Smad binding site is identified in the promoter region of Cthrc1[13], [18]. We show that Cthrc1, which is induced by BMP2, is not required for skeletal development, but is for the maintainance of bone homeostasis, suggesting that Cthrc1 may act as one of the downstream targets of BMP-Smad signaling, followed by enhanced expression of osteoblast specific genes including ALP, Col1a1 and Osteocalcin.
###end p 36
###begin p 37
###xml 153 157 150 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-LeClair1">[14]</xref>
###xml 210 216 207 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col1a1</italic>
###xml 330 336 327 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col1a1</italic>
###xml 362 366 359 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-Pyagay1">[13]</xref>
###xml 368 372 365 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-LeClair1">[14]</xref>
###xml 618 624 615 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 713 719 710 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 740 744 737 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-LeClair1">[14]</xref>
###xml 1190 1196 1187 1193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 1250 1256 1247 1253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col1a1</italic>
###xml 1404 1410 1401 1407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 625 640 <span type="species:ncbi:10090">transgenic mice</span>
###xml 682 697 <span type="species:ncbi:10090">transgenic mice</span>
###xml 753 768 <span type="species:ncbi:10090">transgenic mice</span>
###xml 826 841 <span type="species:ncbi:10090">transgenic mice</span>
###xml 900 915 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1011 1026 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1149 1164 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1343 1358 <span type="species:ncbi:10090">transgenic mice</span>
The detail mechanism of Cthrc1 during bone formation is unclear. Cthrc1 inhibited TGF-beta signaling in smooth muscle cells but not in endotherial cells [14]. Contrary to the effect of Cthrc1 on osteoblasts in Col1a1 expression in our study, overexpression of Cthrc1 in PAC1 cells, smooth muscle cell line, reduced mRNA levels of Col1a1, and collagen deposition [13], [14]. These results suggest that the function of Cthrc1 differs among cell types, or that Cthrc1 signals through its own signaling pathway which is functional in a cell-type specific manner. In addition, there are discrepancies of phenotypes between Cthrc1 transgenic mice which we generated in this study and the transgenic mice overexpressing Cthrc1 previously reported [14]. First, transgenic mice we generated display a high-bone-mass phenotype, whereas transgenic mice previously reported show an osteopenic phenotype. Second, transgenic mice previously reported are smaller in size and have a higher rate of postnatal mortality, whereas transgenic mice we generated are fertile and normal in appearance and body weight. A possible explanation for these discrepancies is that transgenic mice we generated overexpress Cthrc1 specifically in osteoblasts under the control of the Col1a1 2.3kb osteoblast-specific promoter to focus on the function of Cthrc1 in bones, while transgenic mice previously reported ubiquitously overexpress Cthrc1 under the control of cytomegalovirus promoter.
###end p 37
###begin p 38
###xml 121 125 121 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-Wronski1">[19]</xref>
###xml 127 131 127 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-Turner1">[20]</xref>
###xml 346 350 346 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-Dempster1">[21]</xref>
###xml 587 591 583 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-Nakamura1">[22]</xref>
###xml 812 818 808 814 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 863 869 859 865 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 824 828 <span type="species:ncbi:10090">mice</span>
###xml 870 885 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1142 1146 <span type="species:ncbi:10090">mice</span>
###xml 1240 1255 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1296 1300 <span type="species:ncbi:10090">mice</span>
###xml 1371 1386 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1432 1447 <span type="species:ncbi:10090">transgenic mice</span>
Ovariectomy leads to a deficit in bone mineral densities due to cortical bone modeling and resorption of cancellous bone [19], [20]. This change largely results in severe cancellous osteopenia. Dempster et al. demonstrated that the primary mechanism of ovariectomy-induced bone loss is osteoclast perforation and removal of the trabecular plates [21]. Furthermore, a recent study showed that selective ablation of estrogen receptor alpha in differentiated osteoclasts induced trabecular bone loss, similar to the osteoporotic bone phenotype, caused by inhibition of osteoclast apoptosis [22]. Thus, ovariectomy-induced bone loss, a model of postmenopausal osteoporosis, results from an acceleration of osteoclastic bone resorption, followed by high bone turnover in which bone resorption exceeds bone formation. Cthrc1-null mice exhibit cancellous bone loss, and Cthrc1 transgenic mice increase cancellous bone with no change in osteoclastic bone resorption. In addition, Cthrc1 stimulates osteoblast proliferation and differentiation and increases bone formation rates, suggesting that Cthrc1 prevents cancellous bone loss in ovariectomized mice by stimulating osteoblastic bone formation. Indeed, bone volume and trabecular number in OVX transgenic mice were higher than those in OVX wild-type mice, and the loss of trabecular thickness by ovariectomy was protected in transgenic mice. Moreover, increased bone formation rates in transgenic mice were maintained after OVX. Considering that Cthrc1 does not affect osteoclastogenesis, enhanced bone formation by overexpression of Cthrc1 may attenuate bone loss caused by enhanced osteoclastic bone resorption induced by OVX.
###end p 38
###begin p 39
###xml 160 166 160 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 585 589 585 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-Rodan1">[23]</xref>
###xml 786 790 786 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-Canalis1">[24]</xref>
###xml 792 796 792 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-Garrett1">[25]</xref>
###xml 170 174 <span type="species:ncbi:10090">mice</span>
###xml 576 584 <span type="species:ncbi:9606">patients</span>
It is noteworthy in this article that Cthrc1 may have a potential role in treating osteoporosis, because we observed that osteoblast-specific overexpression of Cthrc1 in mice attenuates bone loss which is induced by OVX, an accepted preclinical disease model of postmenopausal osteoporosis. The function of Cthrc1 as a stimulator of bone formation without affecting bone resorption is very promising, because most types of drugs which are currently used for the treatment of osteoporosis are antiresorptive in nature and insufficient for restoring bone volume in osteoporotic patients [23]. Although anabolic agents improve bone mass by stimulating osteoblast-mediated bone formation, only a single anabolic agent, parathyroid hormone 1-34 is available to treat osteoporosis at present [24], [25]. Herein, we indicate that Cthrc1 attenuates estrogen deficiency-induced bone loss by stimulating osteoblastic bone formation. Hence, Cthrc1 constitutes a potential target of an anabolic therapy for osteoporosis and the therapeutic effects are expected to be enhanced with antiresorptive drugs.
###end p 39
###begin title 40
Materials and Methods
###end title 40
###begin title 41
Suppression subtractive hybridization
###end title 41
###begin p 42
###xml 228 229 220 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 346 350 338 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-Kimura1">[26]</xref>
###xml 847 848 839 840 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 948 949 935 936 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1032 1036 1019 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-Kimura1">[26]</xref>
ATDC5 cells were cultured for a total of 5 days in DMEM/Ham's F12 medium supplemented with 5% FBS and 10 microg/ml insulin with medium change every other day. Cells were exposed to 1 microg/ml BMP2 or vehicle for 10 hr. Poly (A)+ RNA was isolated from BMP2 -untreated and BMP2 -treated ATDC5 cells by a single-step method as previously described [26] and analyzed by suppression subtractive hybridization according to the manufacturer's instruction (PCR-Select cDNA Subtractions Kit, Clontech). After subtraction, the cDNAs were ligated into pCR2.1 (Invitrogen), and these subtracted cDNA libraries were further screened by differential hybridization (differential screening kit, Clontech). The cDNA fragment of approximately 500-bp expressed at a high level in BMP2 -treated ATDC5 cells was identified. Oligo (dT) primed cDNA library from poly(A)+ RNA of BMP2 -treated ATDC5 cells was constructed in lambdaZAP Express vector (Stratagene), and 1x106 plaques were screened with the 500-bp fragment as a probe as previously described [26].
###end p 42
###begin title 43
###xml 21 25 <span type="species:ncbi:10090">mice</span>
Generation of mutant mice
###end title 43
###begin p 44
###xml 216 222 216 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 285 300 285 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Protamine 1-Cre</italic>
###xml 470 474 470 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-OGorman1">[27]</xref>
###xml 660 666 660 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 859 865 859 865 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 912 918 912 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 957 983 957 983 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTGCGAGTTCTGTTCAGTGG-3&#8242;</named-content>
###xml 988 1014 988 1014 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGGACTGAAATCGTCAGAGG-3&#8242;</named-content>
###xml 1016 1022 1016 1022 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 1090 1096 1090 1096 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col1a1</italic>
###xml 1149 1155 1149 1155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 1205 1209 1205 1209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-Rossert1">[28]</xref>
###xml 1662 1688 1662 1688 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CATCAAGATGGTATAAAAGG-3&#8242;</named-content>
###xml 1693 1719 1693 1719 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCAGCAGCAGCACAAGGAAG-3&#8242;</named-content>
###xml 43 48 <span type="species:ncbi:10090">mouse</span>
###xml 476 481 <span type="species:ncbi:10090">Mouse</span>
###xml 630 634 <span type="species:ncbi:10090">mice</span>
###xml 667 671 <span type="species:ncbi:10090">mice</span>
###xml 741 745 <span type="species:ncbi:10090">mice</span>
###xml 765 769 <span type="species:ncbi:10090">mice</span>
###xml 1023 1038 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1143 1148 <span type="species:ncbi:10090">mouse</span>
###xml 1177 1181 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 1416 1420 <span type="species:ncbi:10090">mice</span>
###xml 1433 1448 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1585 1590 <span type="species:ncbi:10090">mouse</span>
A Cthrc1 genomic clone was isolated from a mouse 129SvEv genomic DNA library. The targeting vector was constructed by inserting an IRES-LacZ-pA-loxP-flanked neomycin resistance expression cassette into exon 2 of the Cthrc1 gene. Homologous recombination in 129SvEv ES clones harboring Protamine 1-Cre transgenes was identified by Southern blot analysis of SacI-digested genomic DNA using 5' and 3' probes located outside the homology regions used for gene recombination [27]. Mouse chimeras were generated by C57BL/6 host blastocyst injection of mutant embryonic stem cell clones, and the chimeras obtained were bred with C57BL/6 mice to generate heterozygous Cthrc1 mice. Heterozygous mutants were then backcrossed eight times with C57BL/6 mice to generate mutant mice with a C57BL/6 genetic background. We then performed RT-PCR to determine the presence of Cthrc1 transcripts. We used the following primers of Cthrc1 for RT-PCR, based on exon3 and exon4: 5'-CTGCGAGTTCTGTTCAGTGG-3' and 5'-GGGACTGAAATCGTCAGAGG-3'. Cthrc1 transgenic mice were generated using an osteoblast-specific 2.3-kb Col1a1 promoter, the 1.25-kb 3xHA-tagged full-length mouse Cthrc1 cDNA, and the 240-bp SV40 polyadenylation signal [28]. DNAs were injected into pronuclei of fertilized C57BL/6xDBA/2 hybrid eggs, and the injected eggs were then transferred into CD1 foster mothers. Hemizygous mutants were backcrossed eight times with C57BL/6 mice to generate transgenic mice with a C57BL/6 genetic background. The tissue specificity of transgene expression was examined in immunohistochemistry studies. Routine mouse genotyping was performed by PCR. The following primer pairs were used: 5'-CATCAAGATGGTATAAAAGG-3' and 5'-GCAGCAGCAGCACAAGGAAG-3'. The experimental protocols were approved by the Animal Care and Use Committee of Kyoto University.
###end p 44
###begin title 45
Histological analyses
###end title 45
###begin p 46
###xml 76 80 76 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-Nakashima1">[29]</xref>
###xml 396 403 392 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 339 345 <span type="species:ncbi:9986">rabbit</span>
###xml 430 434 <span type="species:ncbi:10090">mice</span>
Whole mount X-gal staining of embryos was performed as previously described [29]. For the histological analyses, we fixed embryos with 4% paraformaldehyde, embedded them in paraffin, and sectioned them into 7-microm-thick slices. Immunohistochemical staining was performed using peroxidase chromogens (Zymed)/TrueBlue substrate (KPL) with rabbit polyclonal anti-HA antibody (1:500, Covance). For in vivo BrdU labeling, 1-week-old mice were injected intraperitoneally with 100 microg/kg BrdU (Amersham) and sacrificed 3 hr later. Sections were stained with anti-BrdU antibody (Amersham) and were counterstained with hematoxylin according to the manufacturer's instruction.
###end p 46
###begin title 47
Micro-CT Analyses
###end title 47
###begin p 48
###xml 158 162 158 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-Nakanishi1">[30]</xref>
###xml 444 448 440 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-Nakanishi1">[30]</xref>
High-resolution micro-CT scanning (SMX-100CT; Shimazu) was performed to measure morphological indices of metaphyseal regions of tibia as previously described [30]. Metaphyseal regions were scanned 100 times with a slice increment of 8 microm. The most proximal slice was defined as the plane where the growth plate had just disappeared. Material properties were calculated using a commercial software package (VG Studio Max1.2: Visual Science) [30].
###end p 48
###begin title 49
Bone Histomorphometry
###end title 49
###begin p 50
###xml 369 373 359 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-Hahn1">[31]</xref>
###xml 550 554 540 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-Parfitt1">[32]</xref>
###xml 556 560 546 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-Parfitt2">[33]</xref>
###xml 4 8 <span type="species:ncbi:10090">mice</span>
###xml 340 344 <span type="species:ncbi:10090">mice</span>
The mice were injected subcutaneously with calcein (20 mg/kg body weight; Sigma) 10 and 3 days before sacrifice. Fifth lumber vertebrae were fixed with 4% paraformaldehyde for 18 hr at 4degreesC. Undecalcified bones were embedded in methylmethacrylate, and 4-microm-thick sections were prepared for bone histomorphometric analyses of adult mice as previously described [31]. Sections were stained with 1% toluidine blue. Static and dynamic histomorphometric analyses were performed according to standard protocols using Histometry RT (SYSTEM-SUPPLY) [32], [33].
###end p 50
###begin title 51
Osteoblast Isolation and Culture
###end title 51
###begin p 52
###xml 60 64 <span type="species:ncbi:10090">mice</span>
Primary osteoblasts were harvested from calvaria of newborn mice by sequential collagenase digestion (Roche) and were maintained in alpha-MEM containing 10% FBS. BrdU incorporation was measured using the cell proliferation ELISA Biotrack kit (Amersham).
###end p 52
###begin title 53
Real-Time PCR
###end title 53
###begin p 54
###xml 530 535 515 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G3pdh</italic>
###xml 537 562 522 547 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TGTCCGTCGTGGATCTGAC-3&#8242;</named-content>
###xml 567 593 552 578 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCTGCTTCACCACCTTCTTG-3&#8242;</named-content>
###xml 595 598 580 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALP</italic>
###xml 600 626 585 611 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ACTCAGGGCAATGAGGTCAC-3&#8242;</named-content>
###xml 631 658 616 643 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CACCCGAGTGGTAGTCACAA -3&#8242;</named-content>
###xml 660 666 645 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col1a1</italic>
###xml 668 694 653 679 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTCCTGGCAAGAATGGAGAT-3&#8242;</named-content>
###xml 699 723 684 708 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AATCCACGAGCACCCTGA-3&#8242;</named-content>
###xml 725 736 710 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Osteocalcin</italic>
###xml 738 762 723 747 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGACTCCGGCGCTACCTT-3&#8242;</named-content>
###xml 767 794 752 779 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTCGTCACAAGCAGGGTTAAG-3&#8242;</named-content>
Primary osteoblasts were cultured in alpha-MEM containing 10% FBS, 50 microg/ml ascorbic acid, and 10 nM beta-glycerophosphate for 10 days, and total RNA was isolated from the cultured cells by RNeasy Mini Kit (Qiagen) according to the manufacturer's instruction. Two microg of total RNA was reverse transcribed to cDNA with the use of Transcriptor First Strand cDNA Synthesis Kit (Roche). Real-time PCR was performed using the LightCycler system with the FastStart DNA Master SYBR Green (Roche). The following primers were used: G3pdh, 5'-TGTCCGTCGTGGATCTGAC-3' and 5'-CCTGCTTCACCACCTTCTTG-3'; ALP, 5'-ACTCAGGGCAATGAGGTCAC-3' and 5'-CACCCGAGTGGTAGTCACAA -3'; Col1a1, 5'-CTCCTGGCAAGAATGGAGAT-3' and 5'-AATCCACGAGCACCCTGA-3'; Osteocalcin, 5'-AGACTCCGGCGCTACCTT-3' and 5'-CTCGTCACAAGCAGGGTTAAG-3'.
###end p 54
###begin title 55
Measurement of CFU-ALP and CFU-O
###end title 55
###begin p 56
###xml 56 60 56 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003174-Kimura1">[26]</xref>
###xml 142 143 142 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 189 190 189 190 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 560 566 549 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 604 610 593 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cthrc1</italic>
###xml 96 100 <span type="species:ncbi:10090">mice</span>
###xml 572 576 <span type="species:ncbi:10090">mice</span>
###xml 611 626 <span type="species:ncbi:10090">transgenic mice</span>
Bone marrow cells were isolated as previously described [26]. Bone marrow cells from 5-week-old mice were plated into 12-well plates at 2.5x106 cells per well for CFU-ALP assays and at 5x106 cells per well for CFU-O assays, and were cultured in alpha-MEM containing 10% FBS, 50 microg/ml ascorbic acid, and 10 nM beta-glycerophosphate. For CFU-ALP assays, cultures were stained at day 10 with Sigma alkaline phosphatase kit (Sigma), and colonies with >20 cells were counted. Cultures were stained with 1% alizarin red S (Wako) at day 20 for the CFU-O assay of Cthrc1-null mice, and at day 16 for that of Cthrc1 transgenic mice, respectively. The stained area was calculated using the freeware Image-J (NIH).
###end p 56
###begin title 57
Ovariectomy
###end title 57
###begin p 58
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
Mice were ovariectomized or sham-operated at 2 months of age, and all of the mice were killed 4 weeks later and the tibiae and vertebrae were removed for analyses.
###end p 58
###begin title 59
Statistical analyses
###end title 59
###begin p 60
###xml 289 290 289 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 148 152 <span type="species:ncbi:10090">mice</span>
Statistical analysis was performed by Student's t test to determine the significance between groups. Wild-type and transgenic OVX and sham-operated mice were analyzed by ANOVA followed by Fisher's protected least significant difference. Values were considered statistically significant at p<0.05.
###end p 60
###begin p 61
###xml 50 57 50 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003174.s005">Text S1</xref>
More methods were shown in Supporting Information Text S1.
###end p 61
###begin title 62
Supporting Information
###end title 62
###begin p 63
###xml 289 294 <span type="species:ncbi:10090">mouse</span>
###xml 392 397 <span type="species:ncbi:10090">mouse</span>
Analyses of Cthrc1 expression in vitro and in vivo by northern blot and in situ hybridization. (A) Effect of BMP2 (1 microg/ml) on Cthrc1 expression in ATDC5 cells. Cthrc1 expression is upregulated by BMP2. (B) Expression of Cthrc1 in various cell lines. (C) Expression of Cthrc1 in adult mouse tissues. (D) In situ hybridization analysis of Cthrc1 expression in limb buds of E13.5 and E16.5 mouse embryos. (E) Expression of Cthrc1 during embryogenesis.
###end p 63
###begin p 64
(8.89 MB TIF)
###end p 64
###begin p 65
Click here for additional data file.
###end p 65
###begin p 66
###xml 47 62 <span type="species:ncbi:10090">transgenic mice</span>
###xml 191 195 <span type="species:ncbi:10090">mice</span>
###xml 211 226 <span type="species:ncbi:10090">transgenic mice</span>
###xml 294 298 <span type="species:ncbi:10090">mice</span>
###xml 316 320 <span type="species:ncbi:10090">mice</span>
###xml 333 348 <span type="species:ncbi:10090">transgenic mice</span>
Skeletal preparation of Cthrc1-null and Cthrc1 transgenic mice. (A) Whole-mount X-gal staining of heterozygous Cthrc1 embryos during embryogenesis. (B and C) Skeletons of newborn Cthrc1-null mice (B) and Cthrc1 transgenic mice (C) stained by alcian blue followed by alizarin red. WT: wild-type mice; KO: Cthrc1-null mice; Tg: Cthrc1 transgenic mice.
###end p 66
###begin p 67
(5.91 MB TIF)
###end p 67
###begin p 68
Click here for additional data file.
###end p 68
###begin p 69
###xml 111 116 <span type="species:ncbi:10090">mouse</span>
###xml 215 220 <span type="species:ncbi:10090">mouse</span>
###xml 252 257 <span type="species:ncbi:10090">mouse</span>
###xml 281 285 <span type="species:ncbi:10090">mice</span>
###xml 303 307 <span type="species:ncbi:10090">mice</span>
###xml 320 335 <span type="species:ncbi:10090">transgenic mice</span>
In situ hybridization analyses of osteoblast and chondrocyte marker genes in Cthrc1-null and Cthrc1 transgenic mouse embryos. Runx2, Col1a1, Col2a1 and Col10a1 expression in humeri of E16.5 embryos. (A) Cthrc1-null mouse embryos. (B) Cthrc1 transgenic mouse embryos. WT: wild-type mice; KO: Cthrc1-null mice; Tg: Cthrc1 transgenic mice.
###end p 69
###begin p 70
(10.15 MB TIF)
###end p 70
###begin p 71
Click here for additional data file.
###end p 71
###begin p 72
###xml 112 116 <span type="species:ncbi:10090">mice</span>
###xml 312 316 <span type="species:ncbi:10090">mice</span>
###xml 423 427 <span type="species:ncbi:10090">mice</span>
###xml 618 633 <span type="species:ncbi:10090">transgenic mice</span>
###xml 676 680 <span type="species:ncbi:10090">mice</span>
###xml 698 702 <span type="species:ncbi:10090">mice</span>
###xml 715 730 <span type="species:ncbi:10090">transgenic mice</span>
Effect of Cthrc1 on osteoclastogenesis. (A) TRAP staining of vertebrae of 2-month-old Cthrc1-null and wild-type mice. TRAP-positive osteoclast number/bone surface (Oc.N/BS) and osteoclast surface/bone surface (Oc.S/BS) are shown (n = 6). (B) Expression of RANKL in primary osteoblasts harvested from Cthrc1-null mice, assessed by real-time PCR. (C) TRAP staining of vertebrae of 2-month-old Cthrc1 transgenic and wild-type mice. TRAP-positive osteoclast number/bone surface (Oc.N/BS) and osteoclast surface/bone surface (Oc.S/BS) are shown (n = 6). (D) Expression of RANKL in primary osteoblasts harvested from Cthrc1 transgenic mice, assessed by real-time PCR. WT: wild-type mice; KO: Cthrc1-null mice; Tg: Cthrc1 transgenic mice. Data are shown as the mean+/-SEM (*p<0.05).
###end p 72
###begin p 73
(9.83 MB TIF)
###end p 73
###begin p 74
Click here for additional data file.
###end p 74
###begin p 75
Supplementary Methods.
###end p 75
###begin p 76
(0.05 MB DOC)
###end p 76
###begin p 77
Click here for additional data file.
###end p 77
###begin p 78
###xml 128 133 <span type="species:ncbi:10090">mouse</span>
We thank Janie Finch for editorial assistance, Neung-Seon Seo and Magnus Hook for technical support, and Steve O'Gorman for PC3 mouse ES cells.
###end p 78
###begin title 79
References
###end title 79
###begin article-title 80
Bone development.
###end article-title 80
###begin article-title 81
Reaching a genetic and molecular understanding of skeletal development.
###end article-title 81
###begin article-title 82
Control of osteoblast function and regulation of bone mass.
###end article-title 82
###begin article-title 83
###xml 78 81 <span type="species:ncbi:10116">rat</span>
The effects of bone morphogenetic protein-2, -4, and -6 on differentiation of rat osteoblast cells in vitro.
###end article-title 83
###begin article-title 84
###xml 82 88 <span type="species:ncbi:10090">murine</span>
###xml 121 125 <span type="species:ncbi:10090">mice</span>
Essential requirement of BMPs-2/4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice: antagonism by noggin.
###end article-title 84
###begin article-title 85
Developmental regulation of the growth plate.
###end article-title 85
###begin article-title 86
Function of BMPs and BMP antagonists in adult bone.
###end article-title 86
###begin article-title 87
Skeletal overexpression of noggin results in osteopenia and reduced bone formation.
###end article-title 87
###begin article-title 88
###xml 112 116 <span type="species:ncbi:10090">mice</span>
Impaired osteoblastic differentiation, reduced bone formation, and severe osteoporosis in noggin-overexpressing mice.
###end article-title 88
###begin article-title 89
###xml 70 76 <span type="species:ncbi:10090">murine</span>
Bone morphogenetic protein receptor signaling is necessary for normal murine postnatal bone formation.
###end article-title 89
###begin article-title 90
Bone morphogenetic protein type IA receptor signaling regulates postnatal osteoblast function and bone remodeling.
###end article-title 90
###begin article-title 91
Negative regulation of BMP/Smad signaling by Tob in osteoblasts.
###end article-title 91
###begin article-title 92
Collagen triple helix repeat containing 1, a novel secreted protein in injured and diseased arteries, inhibits collagen expression and promotes cell migration.
###end article-title 92
###begin article-title 93
Cthrc1 is a novel inhibitor of transforming growth factor-beta signaling and neointimal lesion formation.
###end article-title 93
###begin article-title 94
Expression analysis of the novel gene collagen triple helix repeat containing-1 (Cthrc1).
###end article-title 94
###begin article-title 95
###xml 19 22 <span type="species:ncbi:10116">rat</span>
The ovariectomized rat model of postmenopausal bone loss.
###end article-title 95
###begin article-title 96
Novel regulators of bone formation: molecular clones and activities.
###end article-title 96
###begin article-title 97
###xml 68 73 <span type="species:ncbi:9606">human</span>
Aberrant expression of collagen triple helix repeat containing 1 in human solid cancers.
###end article-title 97
###begin article-title 98
###xml 86 90 <span type="species:ncbi:10116">rats</span>
Temporal relationship between bone loss and increased bone turnover in ovariectomized rats.
###end article-title 98
###begin article-title 99
###xml 94 98 <span type="species:ncbi:10116">rats</span>
The effects of ovariectomy and 17 beta-estradiol on cortical bone histomorphometry in growing rats.
###end article-title 99
###begin article-title 100
###xml 49 53 <span type="species:ncbi:10116">rats</span>
Temporal changes in cancellous bone structure of rats immediately after ovariectomy.
###end article-title 100
###begin article-title 101
Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts.
###end article-title 101
###begin article-title 102
Therapeutic approaches to bone diseases.
###end article-title 102
###begin article-title 103
Mechanisms of anabolic therapies for osteoporosis.
###end article-title 103
###begin article-title 104
Anabolic agents and the bone morphogenetic protein pathway.
###end article-title 104
###begin article-title 105
Tenascin-W inhibits proliferation and differentiation of preosteoblasts during endochondral bone formation.
###end article-title 105
###begin article-title 106
###xml 101 105 <span type="species:ncbi:10090">mice</span>
Protamine-Cre recombinase transgenes efficiently recombine target sequences in the male germ line of mice, but not in embryonic stem cells.
###end article-title 106
###begin article-title 107
###xml 40 45 <span type="species:ncbi:10090">mouse</span>
###xml 163 178 <span type="species:ncbi:10090">transgenic mice</span>
Separate cis-acting DNA elements of the mouse pro-alpha 1(I) collagen promoter direct expression of reporter genes to different type I collagen-producing cells in transgenic mice.
###end article-title 107
###begin article-title 108
The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation.
###end article-title 108
###begin article-title 109
###xml 81 85 <span type="species:ncbi:10090">mice</span>
Secreted frizzled-related protein 4 is a negative regulator of peak BMD in SAMP6 mice.
###end article-title 109
###begin article-title 110
Undecalcified preparation of bone tissue: report of technical experience and development of new methods.
###end article-title 110
###begin article-title 111
Physiologic and pathogenetic significance of bone histomorphometric data.
###end article-title 111
###begin article-title 112
Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee.
###end article-title 112
###begin p 113
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 113
###begin p 114
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by a Grant-in-aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (#18390413).
###end p 114

